PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
PMC1252725	PMC1252725_0	[0]	[324]	['Evaluation of maternal infusion therapy during pregnancy for fetal development\n\nAbstract\nThe aim of this project was to study the possible association between maternal infusion treatments during pregnancy and variables of fetal development as well as the occurrence of congenital abnormalities (CA) in a case-control design.']	aim	QUESTION_ANSWERED_BY_THIS_WORK	[93]	[96]	PMC1252725_T160
PMC1252725	PMC1252725_0	[0]	[324]	['Evaluation of maternal infusion therapy during pregnancy for fetal development\n\nAbstract\nThe aim of this project was to study the possible association between maternal infusion treatments during pregnancy and variables of fetal development as well as the occurrence of congenital abnormalities (CA) in a case-control design.']	this	QUESTION_ANSWERED_BY_THIS_WORK	[100]	[104]	PMC1252725_T161
PMC1252725	PMC1252725_0	[0]	[324]	['Evaluation of maternal infusion therapy during pregnancy for fetal development\n\nAbstract\nThe aim of this project was to study the possible association between maternal infusion treatments during pregnancy and variables of fetal development as well as the occurrence of congenital abnormalities (CA) in a case-control design.']	possible	INCOMPLETE_EVIDENCE	[130]	[138]	PMC1252725_T4
PMC1252725	PMC1252725_0	[0]	[324]	['Evaluation of maternal infusion therapy during pregnancy for fetal development\n\nAbstract\nThe aim of this project was to study the possible association between maternal infusion treatments during pregnancy and variables of fetal development as well as the occurrence of congenital abnormalities (CA) in a case-control design.']	association	SUPERFICIAL_RELATIONSHIP	[139]	[150]	PMC1252725_T79
PMC1252725	PMC1252725_6	[1393]	[1533]	['The results of the study suggest that infusion treatment of pregnant women did not associate with a higher risk of congenital abnormalities.']	suggest	INCOMPLETE_EVIDENCE	[1418]	[1425]	PMC1252725_T5
PMC1252725	PMC1252725_7	[1534]	[1701]	['In addition, the intravenous infusion of drugs has some, but limited efficacy to prevent the adverse effects of hyperemesis gravidarum and threatened preterm delivery.']	some	INCOMPLETE_EVIDENCE	[1585]	[1589]	PMC1252725_T6
PMC1252725	PMC1252725_7	[1534]	[1701]	['In addition, the intravenous infusion of drugs has some, but limited efficacy to prevent the adverse effects of hyperemesis gravidarum and threatened preterm delivery.']	but	ALTERNATIVE_OPTIONS_CONTROVERSY	[1591]	[1594]	PMC1252725_T133
PMC1252725	PMC1252725_7	[1534]	[1701]	['In addition, the intravenous infusion of drugs has some, but limited efficacy to prevent the adverse effects of hyperemesis gravidarum and threatened preterm delivery.']	limited	INCOMPLETE_EVIDENCE	[1595]	[1602]	PMC1252725_T7
PMC1252725	PMC1252725_7	[1534]	[1701]	['In addition, the intravenous infusion of drugs has some, but limited efficacy to prevent the adverse effects of hyperemesis gravidarum and threatened preterm delivery.']	effects	SUPERFICIAL_RELATIONSHIP	[1635]	[1642]	PMC1252725_T80
PMC1252725	PMC1252725_9	[1706]	[2096]	['Introduction\nThe effect of drugs during pregnancy is determined beyond the chemical structure of product, the treatment time during gestation, dose, duration of treatment, underlying diseases and pregnancy complications, other drugs due to their possible interaction and last but not least the type of administration: oral, rectal, vaginal, ophthalmic, otic, nasal, topical and parenteral1.']	effect	SUPERFICIAL_RELATIONSHIP	[1723]	[1729]	PMC1252725_T81
PMC1252725	PMC1252725_9	[1706]	[2096]	['Introduction\nThe effect of drugs during pregnancy is determined beyond the chemical structure of product, the treatment time during gestation, dose, duration of treatment, underlying diseases and pregnancy complications, other drugs due to their possible interaction and last but not least the type of administration: oral, rectal, vaginal, ophthalmic, otic, nasal, topical and parenteral1.']	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[1927]	[1932]	PMC1252725_T134
PMC1252725	PMC1252725_9	[1706]	[2096]	['Introduction\nThe effect of drugs during pregnancy is determined beyond the chemical structure of product, the treatment time during gestation, dose, duration of treatment, underlying diseases and pregnancy complications, other drugs due to their possible interaction and last but not least the type of administration: oral, rectal, vaginal, ophthalmic, otic, nasal, topical and parenteral1.']	due to	PROBLEM_COMPLICATION	[1939]	[1945]	PMC1252725_T152
PMC1252725	PMC1252725_9	[1706]	[2096]	['Introduction\nThe effect of drugs during pregnancy is determined beyond the chemical structure of product, the treatment time during gestation, dose, duration of treatment, underlying diseases and pregnancy complications, other drugs due to their possible interaction and last but not least the type of administration: oral, rectal, vaginal, ophthalmic, otic, nasal, topical and parenteral1.']	possible	INCOMPLETE_EVIDENCE	[1952]	[1960]	PMC1252725_T8
PMC1252725	PMC1252725_9	[1706]	[2096]	['Introduction\nThe effect of drugs during pregnancy is determined beyond the chemical structure of product, the treatment time during gestation, dose, duration of treatment, underlying diseases and pregnancy complications, other drugs due to their possible interaction and last but not least the type of administration: oral, rectal, vaginal, ophthalmic, otic, nasal, topical and parenteral1.']	interaction	SUPERFICIAL_RELATIONSHIP	[1961]	[1972]	PMC1252725_T82
PMC1252725	PMC1252725_9	[1706]	[2096]	['Introduction\nThe effect of drugs during pregnancy is determined beyond the chemical structure of product, the treatment time during gestation, dose, duration of treatment, underlying diseases and pregnancy complications, other drugs due to their possible interaction and last but not least the type of administration: oral, rectal, vaginal, ophthalmic, otic, nasal, topical and parenteral1.']	but not	ALTERNATIVE_OPTIONS_CONTROVERSY	[1982]	[1989]	PMC1252725_T135
PMC1252725	PMC1252725_12	[2323]	[2593]	['Clinical studies have shown that intravenous infusion of certain drugs is more effective than other administrations due to immediate drug action4; in addition, intravenous fluids are used for many sick and injured patients to treat dehydration and loss of electrolytes5.']	studies	INCOMPLETE_EVIDENCE	[2332]	[2339]	PMC1252725_T9
PMC1252725	PMC1252725_12	[2323]	[2593]	['Clinical studies have shown that intravenous infusion of certain drugs is more effective than other administrations due to immediate drug action4; in addition, intravenous fluids are used for many sick and injured patients to treat dehydration and loss of electrolytes5.']	have shown	INCOMPLETE_EVIDENCE	[2340]	[2350]	PMC1252725_T10
PMC1252725	PMC1252725_12	[2323]	[2593]	['Clinical studies have shown that intravenous infusion of certain drugs is more effective than other administrations due to immediate drug action4; in addition, intravenous fluids are used for many sick and injured patients to treat dehydration and loss of electrolytes5.']	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[2417]	[2422]	PMC1252725_T136
PMC1252725	PMC1252725_13	[2594]	[2892]	['Infusion treatment is also used in pregnant women particularly for prolonging pregnancy in women at risk for preterm delivery6, with extreme severe nausea-vomiting (the so-called hyperemesis gravidarum)7,8and after surgery large volumes of hypotonic fluid are generally given to pregnant women9,10.']	at risk	IMPORTANT_CONSIDERATION	[2691]	[2698]	PMC1252725_T109
PMC1252725	PMC1252725_13	[2594]	[2892]	['Infusion treatment is also used in pregnant women particularly for prolonging pregnancy in women at risk for preterm delivery6, with extreme severe nausea-vomiting (the so-called hyperemesis gravidarum)7,8and after surgery large volumes of hypotonic fluid are generally given to pregnant women9,10.']	severe	IMPORTANT_CONSIDERATION	[2735]	[2741]	PMC1252725_T110
PMC1252725	PMC1252725_13	[2594]	[2892]	['Infusion treatment is also used in pregnant women particularly for prolonging pregnancy in women at risk for preterm delivery6, with extreme severe nausea-vomiting (the so-called hyperemesis gravidarum)7,8and after surgery large volumes of hypotonic fluid are generally given to pregnant women9,10.']	generally	PROBABLE_UNDERSTANDING	[2854]	[2863]	PMC1252725_T61
PMC1252725	PMC1252725_14	[2893]	[3093]	['As Friedman and Polifka11stated, the effect of infusion treatments during pregnancy was rarely studied for fetal development, and only the effect of specific drugs used by infusion was evaluated12,13.']	effect	SUPERFICIAL_RELATIONSHIP	[2930]	[2936]	PMC1252725_T83
PMC1252725	PMC1252725_14	[2893]	[3093]	['As Friedman and Polifka11stated, the effect of infusion treatments during pregnancy was rarely studied for fetal development, and only the effect of specific drugs used by infusion was evaluated12,13.']	rarely	INCOMPLETE_EVIDENCE	[2981]	[2987]	PMC1252725_T11
PMC1252725	PMC1252725_14	[2893]	[3093]	['As Friedman and Polifka11stated, the effect of infusion treatments during pregnancy was rarely studied for fetal development, and only the effect of specific drugs used by infusion was evaluated12,13.']	only	INCOMPLETE_EVIDENCE	[3023]	[3027]	PMC1252725_T12
PMC1252725	PMC1252725_14	[2893]	[3093]	['As Friedman and Polifka11stated, the effect of infusion treatments during pregnancy was rarely studied for fetal development, and only the effect of specific drugs used by infusion was evaluated12,13.']	effect	SUPERFICIAL_RELATIONSHIP	[3032]	[3038]	PMC1252725_T84
PMC1252725	PMC1252725_15	[3094]	[3567]	['The population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA 1980-1996)14is ideal for us to check the possible association between maternal infusion therapy during pregnancy and the occurrence of congenital abnormalities (CAs), in addition to study gestational age, birth weight, the proportion of preterm birth and low birthweight in control newborn infants without CA born to mothers with or without infusion therapy.']	14is	PROBABLE_UNDERSTANDING	[3219]	[3223]	PMC1252725_T62
PMC1252725	PMC1252725_15	[3094]	[3567]	['The population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA 1980-1996)14is ideal for us to check the possible association between maternal infusion therapy during pregnancy and the occurrence of congenital abnormalities (CAs), in addition to study gestational age, birth weight, the proportion of preterm birth and low birthweight in control newborn infants without CA born to mothers with or without infusion therapy.']	ideal	IMPORTANT_CONSIDERATION	[3224]	[3229]	PMC1252725_T111
PMC1252725	PMC1252725_15	[3094]	[3567]	['The population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA 1980-1996)14is ideal for us to check the possible association between maternal infusion therapy during pregnancy and the occurrence of congenital abnormalities (CAs), in addition to study gestational age, birth weight, the proportion of preterm birth and low birthweight in control newborn infants without CA born to mothers with or without infusion therapy.']	ideal	PROBABLE_UNDERSTANDING	[3224]	[3229]	PMC1252725_T63
PMC1252725	PMC1252725_15	[3094]	[3567]	['The population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA 1980-1996)14is ideal for us to check the possible association between maternal infusion therapy during pregnancy and the occurrence of congenital abnormalities (CAs), in addition to study gestational age, birth weight, the proportion of preterm birth and low birthweight in control newborn infants without CA born to mothers with or without infusion therapy.']	possible	INCOMPLETE_EVIDENCE	[3250]	[3258]	PMC1252725_T13
PMC1252725	PMC1252725_15	[3094]	[3567]	['The population-based large data set of the Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA 1980-1996)14is ideal for us to check the possible association between maternal infusion therapy during pregnancy and the occurrence of congenital abnormalities (CAs), in addition to study gestational age, birth weight, the proportion of preterm birth and low birthweight in control newborn infants without CA born to mothers with or without infusion therapy.']	association	SUPERFICIAL_RELATIONSHIP	[3259]	[3270]	PMC1252725_T85
PMC1252725	PMC1252725_18	[3728]	[4083]	['Notification of cases with CAs is compulsory for physicians, and most are reported by obstetricians (in Hungary practically all deliveries occur in inpatient obstetric units and birth attendants are obstetricians) and paediatricians (who work in the neonatal units of inpatient obstetric clinics or in various inpatient and outpatient paediatric clinics).']	reported	INCOMPLETE_EVIDENCE	[3802]	[3810]	PMC1252725_T14
PMC1252725	PMC1252725_18	[3728]	[4083]	['Notification of cases with CAs is compulsory for physicians, and most are reported by obstetricians (in Hungary practically all deliveries occur in inpatient obstetric units and birth attendants are obstetricians) and paediatricians (who work in the neonatal units of inpatient obstetric clinics or in various inpatient and outpatient paediatric clinics).']	practically	PROBABLE_UNDERSTANDING	[3840]	[3851]	PMC1252725_T64
PMC1252725	PMC1252725_24	[4852]	[5073]	['This shorter time between “pregnancy end” and data collection increases the accuracy of information about pregnancy history without undue loss of power since 77% of cases were reported during this time window to the HCAR.']	reported	INCOMPLETE_EVIDENCE	[5028]	[5036]	PMC1252725_T15
PMC1252725	PMC1252725_25	[5074]	[5367]	['Secondly, three mild CAs (such as congenital dislocation of hip based on Ortolani click, congenital inguinal hernia, and large haemangioma), minor anomalies-variants (e.g., umbilical hernia, hydrocele, small haemangioma) and CA‑syndromes of known Mendelian or chromosomal origin were excluded.']	excluded	INCOMPLETE_EVIDENCE	[5358]	[5366]	PMC1252725_T16
PMC1252725	PMC1252725_27	[5537]	[5669]	["In general, two control newborn infants were matched to every case according to sex, birth week, and district of parents' residence."]	In general	PROBABLE_UNDERSTANDING	[5537]	[5547]	PMC1252725_T65
PMC1252725	PMC1252725_46	[7904]	[7965]	['The personal data of controls are not recorded in the HCCSCA.']	not recorded	FULL_UNKNOWN	[7938]	[7950]	PMC1252725_T0
PMC1252725	PMC1252725_51	[8316]	[8448]	['Pregnancy supplements (such as calcium, iron, and vitamins) and infusion used for labour induction were excluded from this analysis.']	excluded	INCOMPLETE_EVIDENCE	[8420]	[8428]	PMC1252725_T17
PMC1252725	PMC1252725_53	[8497]	[8861]	['Gestational age was calculated from the first day of last menstrual period and three time intervals were considered: (i) the first month of pregnancy, which is before organogenesis; (ii) the second and third months of gestation, considered the most sensitive, and the so-called critical period for most major CAs; and (iii) the fourth to ninth months of gestation.']	considered	INCOMPLETE_EVIDENCE	[8726]	[8736]	PMC1252725_T18
PMC1252725	PMC1252725_57	[9191]	[9326]	['Cases with CAs were excluded from this analysis because CAs may have a more drastic effect for these variables than infusion treatment.']	excluded	INCOMPLETE_EVIDENCE	[9211]	[9219]	PMC1252725_T19
PMC1252725	PMC1252725_57	[9191]	[9326]	['Cases with CAs were excluded from this analysis because CAs may have a more drastic effect for these variables than infusion treatment.']	may	INCOMPLETE_EVIDENCE	[9251]	[9254]	PMC1252725_T20
PMC1252725	PMC1252725_57	[9191]	[9326]	['Cases with CAs were excluded from this analysis because CAs may have a more drastic effect for these variables than infusion treatment.']	effect	SUPERFICIAL_RELATIONSHIP	[9275]	[9281]	PMC1252725_T86
PMC1252725	PMC1252725_57	[9191]	[9326]	['Cases with CAs were excluded from this analysis because CAs may have a more drastic effect for these variables than infusion treatment.']	variables	SUPERFICIAL_RELATIONSHIP	[9292]	[9301]	PMC1252725_T87
PMC1252725	PMC1252725_58	[9327]	[9523]	['Potential confounding factors, as maternal age, birth order, marital and employment status of mothers (as indicators of socioeconomic status), pregnancy complications and drug uses were evaluated.']	confounding factors	PROBLEM_COMPLICATION	[9337]	[9356]	PMC1252725_T153
PMC1252725	PMC1252725_58	[9327]	[9523]	['Potential confounding factors, as maternal age, birth order, marital and employment status of mothers (as indicators of socioeconomic status), pregnancy complications and drug uses were evaluated.']	as	PROBABLE_UNDERSTANDING	[9430]	[9432]	PMC1252725_T66
PMC1252725	PMC1252725_61	[9839]	[10041]	['Second, quantitative confounders such as maternal age, birth order, were compared using Student t test while POR with 95% CI were calculated for marital status and chi square test for employment status.']	confounders	PROBLEM_COMPLICATION	[9860]	[9871]	PMC1252725_T154
PMC1252725	PMC1252725_65	[10543]	[10741]	['Sixth, the prevalence of maternal infusion treatment in the CA-groups was compared with the prevalence of this treatment in total controls as reference using unconditional logistic regression model.']	model	INCOMPLETE_EVIDENCE	[10735]	[10740]	PMC1252725_T21
PMC1252725	PMC1252725_68	[11038]	[11177]	['Results\nDuring the study period, 2,146,574 babies were born in Hungary; therefore 38,151 controls represented 1.8% of the Hungarian births.']	represented	PROBABLE_UNDERSTANDING	[11136]	[11147]	PMC1252725_T67
PMC1252725	PMC1252725_73	[11587]	[11717]	['It is worth mentioning that pregnant women with infusion were younger with lower birth order than the mothers in the total groups.']	worth mentioning	IMPORTANT_CONSIDERATION	[11593]	[11609]	PMC1252725_T112
PMC1252725	PMC1252725_74	[11718]	[11907]	['Mean maternal age did not show significant difference between case and control pregnant women with infusion, while the mean birth order was lower in the group of case mothers with infusion.']	did not	ANOMALY_CURIOUS_FINDING	[11736]	[11743]	PMC1252725_T120
PMC1252725	PMC1252725_74	[11718]	[11907]	['Mean maternal age did not show significant difference between case and control pregnant women with infusion, while the mean birth order was lower in the group of case mothers with infusion.']	while	ANOMALY_CURIOUS_FINDING	[11827]	[11832]	PMC1252725_T121
PMC1252725	PMC1252725_75	[11908]	[12069]	['There was no obvious difference in the proportion of unmarried women and in the distribution of employment status between case and control mothers with infusion.']	There was no	FULL_UNKNOWN	[11908]	[11920]	PMC1252725_T1
PMC1252725	PMC1252725_77	[12132]	[12316]	['These data reflect the three main reasons of maternal infusion: (i) threatened preterm delivery in about half of mothers; (ii) hyperemesis gravidarum; and (iii) surgical interventions.']	reflect	SUPERFICIAL_RELATIONSHIP	[12143]	[12150]	PMC1252725_T88
PMC1252725	PMC1252725_79	[12456]	[12596]	['However, there was no significant difference in the prevalence of pregnancy complications between the case and control groups with infusion.']	However	ANOMALY_CURIOUS_FINDING	[12456]	[12463]	PMC1252725_T122
PMC1252725	PMC1252725_79	[12456]	[12596]	['However, there was no significant difference in the prevalence of pregnancy complications between the case and control groups with infusion.']	complications	PROBLEM_COMPLICATION	[12532]	[12545]	PMC1252725_T155
PMC1252725	PMC1252725_82	[12759]	[12877]	['The first peak was connected with the treatment of hyperemesis gravidarum in the second and third months of gestation.']	connected	SUPERFICIAL_RELATIONSHIP	[12778]	[12787]	PMC1252725_T89
PMC1252725	PMC1252725_83	[12878]	[13024]	['The reason of second peak in the infusion treatments can be explained by threatened preterm delivery in the seventh and eighth month of gestation.']	reason	PROBABLE_UNDERSTANDING	[12882]	[12888]	PMC1252725_T68
PMC1252725	PMC1252725_83	[12878]	[13024]	['The reason of second peak in the infusion treatments can be explained by threatened preterm delivery in the seventh and eighth month of gestation.']	can	INCOMPLETE_EVIDENCE	[12931]	[12934]	PMC1252725_T22
PMC1252725	PMC1252725_83	[12878]	[13024]	['The reason of second peak in the infusion treatments can be explained by threatened preterm delivery in the seventh and eighth month of gestation.']	be	PROBABLE_UNDERSTANDING	[12935]	[12937]	PMC1252725_T69
PMC1252725	PMC1252725_83	[12878]	[13024]	['The reason of second peak in the infusion treatments can be explained by threatened preterm delivery in the seventh and eighth month of gestation.']	explained	PROBABLE_UNDERSTANDING	[12938]	[12947]	PMC1252725_T70
PMC1252725	PMC1252725_84	[13025]	[13144]	['Mothers with surgical interventions are not evaluated here because these pregnant women were evaluated previously (10).']	not evaluated	FULL_UNKNOWN	[13065]	[13078]	PMC1252725_T2
PMC1252725	PMC1252725_84	[13025]	[13144]	['Mothers with surgical interventions are not evaluated here because these pregnant women were evaluated previously (10).']	here	QUESTION_ANSWERED_BY_THIS_WORK	[13079]	[13083]	PMC1252725_T162
PMC1252725	PMC1252725_85	[13145]	[13227]	['As we previously mentioned, labour induction was also excluded from this analysis.']	previously	INCOMPLETE_EVIDENCE	[13151]	[13161]	PMC1252725_T23
PMC1252725	PMC1252725_89	[14004]	[14426]	['The reason of infusion for threatened preterm delivery was the so-called tocolysis, terbutaline (Bricanyl®) (5 mg per 1000 ml isotonic sodium chloride solution, 1 ml contains 5 μg for 8 h with a starting speed of 10 μg/min contained by 5 μg/min) and fenoterol (Partusisten®) (0.5 mg per 250-500 ml 5% glucose solution with a speed of 0.5-3.0 μg/min) were used for this purpose sometimes combined by verapamil (Verapamil®).']	so - called	INCOMPLETE_EVIDENCE	[14067]	[14076]	PMC1252725_T24
PMC1252725	PMC1252725_90	[14427]	[14504]	['The occurrence of other frequently used drugs (antibiotics, analgesics, etc.)']	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[14445]	[14450]	PMC1252725_T137
PMC1252725	PMC1252725_91	[14505]	[14589]	['did not show significant differences between case and control mothers with infusion.']	did not	INCOMPLETE_EVIDENCE	[14505]	[14512]	PMC1252725_T25
PMC1252725	PMC1252725_94	[14945]	[15127]	['On the other hand the maternal infusion during the study pregnancy showed a lower occurrence in two CA‑groups: hypospadias and multiple CAs (which include heterogeneous CA-entities).']	On the other hand	ALTERNATIVE_OPTIONS_CONTROVERSY	[14945]	[14962]	PMC1252725_T138
PMC1252725	PMC1252725_96	[15247]	[15348]	['It is worth focusing the second and third months of gestation, the critical period of most major CAs.']	worth	IMPORTANT_CONSIDERATION	[15253]	[15258]	PMC1252725_T113
PMC1252725	PMC1252725_97	[15349]	[15467]	['We did not find a higher prevalence of infusion treatment in any CA group, but the number of case mothers was limited.']	did not find	INCOMPLETE_EVIDENCE	[15352]	[15364]	PMC1252725_T26
PMC1252725	PMC1252725_97	[15349]	[15467]	['We did not find a higher prevalence of infusion treatment in any CA group, but the number of case mothers was limited.']	limited	INCOMPLETE_EVIDENCE	[15459]	[15466]	PMC1252725_T27
PMC1252725	PMC1252725_99	[15618]	[15853]	['This approach showed a higher adjusted POR with 95% CI for renal a/dysgenesis (4.4, 1.4-14.1), however, this possible association was based on 3 cases and two offspring had mothers with infusion after the third month of gestation (i.e.']	showed	INCOMPLETE_EVIDENCE	[15632]	[15638]	PMC1252725_T28
PMC1252725	PMC1252725_99	[15618]	[15853]	['This approach showed a higher adjusted POR with 95% CI for renal a/dysgenesis (4.4, 1.4-14.1), however, this possible association was based on 3 cases and two offspring had mothers with infusion after the third month of gestation (i.e.']	however	ALTERNATIVE_OPTIONS_CONTROVERSY	[15713]	[15720]	PMC1252725_T139
PMC1252725	PMC1252725_99	[15618]	[15853]	['This approach showed a higher adjusted POR with 95% CI for renal a/dysgenesis (4.4, 1.4-14.1), however, this possible association was based on 3 cases and two offspring had mothers with infusion after the third month of gestation (i.e.']	possible	INCOMPLETE_EVIDENCE	[15727]	[15735]	PMC1252725_T29
PMC1252725	PMC1252725_99	[15618]	[15853]	['This approach showed a higher adjusted POR with 95% CI for renal a/dysgenesis (4.4, 1.4-14.1), however, this possible association was based on 3 cases and two offspring had mothers with infusion after the third month of gestation (i.e.']	association	SUPERFICIAL_RELATIONSHIP	[15736]	[15747]	PMC1252725_T90
PMC1252725	PMC1252725_99	[15618]	[15853]	['This approach showed a higher adjusted POR with 95% CI for renal a/dysgenesis (4.4, 1.4-14.1), however, this possible association was based on 3 cases and two offspring had mothers with infusion after the third month of gestation (i.e.']	on	INCOMPLETE_EVIDENCE	[15758]	[15760]	PMC1252725_T30
PMC1252725	PMC1252725_101	[15893]	[16042]	['The lower prevalence of infusion in the mothers with children affected with hypospadias (0.4, 0.2-0.8) and multiple CAs (0.2, 0.1-0.8) was confirmed.']	confirmed	INCOMPLETE_EVIDENCE	[16032]	[16041]	PMC1252725_T31
PMC1252725	PMC1252725_105	[16398]	[16569]	['These trends were in agreement with the higher rate of preterm birth (16.4% vs. 9.1%) and low birthweight (12.6% vs. 5.6%) of newborn infants born to mother with infusion.']	trends	INCOMPLETE_EVIDENCE	[16404]	[16410]	PMC1252725_T32
PMC1252725	PMC1252725_105	[16398]	[16569]	['These trends were in agreement with the higher rate of preterm birth (16.4% vs. 9.1%) and low birthweight (12.6% vs. 5.6%) of newborn infants born to mother with infusion.']	in agreement	INCOMPLETE_EVIDENCE	[16416]	[16428]	PMC1252725_T33
PMC1252725	PMC1252725_106	[16570]	[16834]	['These differences were more obvious in women who had infusion in the sixth-ninth month of gestation: mean gestational age was 38.1 ± 2.6 and 39.4 ± 2.0 week, while mean birth weight 2,941 ± 529 and 3,277 ± 311 gram in women with and without infusion, respectively.']	differences	ALTERNATIVE_OPTIONS_CONTROVERSY	[16576]	[16587]	PMC1252725_T140
PMC1252725	PMC1252725_107	[16835]	[17031]	['On the other hand the mean gestational age (39.4 ± 2.5 vs. 39.4 ± 2.0 week) in control women with or without infusion was similar between the second and fifth months due to hyperemesis gravidarum.']	On the other hand	ALTERNATIVE_OPTIONS_CONTROVERSY	[16835]	[16852]	PMC1252725_T141
PMC1252725	PMC1252725_107	[16835]	[17031]	['On the other hand the mean gestational age (39.4 ± 2.5 vs. 39.4 ± 2.0 week) in control women with or without infusion was similar between the second and fifth months due to hyperemesis gravidarum.']	similar	SUPERFICIAL_RELATIONSHIP	[16957]	[16964]	PMC1252725_T91
PMC1252725	PMC1252725_110	[17216]	[17415]	['Discussion\nOur study is the first to evaluate the possible association in general between the effect of maternal infusion treatments during pregnancy and the different variables of fetal development.']	Our study	QUESTION_ANSWERED_BY_THIS_WORK	[17227]	[17236]	PMC1252725_T163
PMC1252725	PMC1252725_110	[17216]	[17415]	['Discussion\nOur study is the first to evaluate the possible association in general between the effect of maternal infusion treatments during pregnancy and the different variables of fetal development.']	first	INCOMPLETE_EVIDENCE	[17244]	[17249]	PMC1252725_T34
PMC1252725	PMC1252725_110	[17216]	[17415]	['Discussion\nOur study is the first to evaluate the possible association in general between the effect of maternal infusion treatments during pregnancy and the different variables of fetal development.']	to evaluate	QUESTION_ANSWERED_BY_THIS_WORK	[17250]	[17261]	PMC1252725_T164
PMC1252725	PMC1252725_110	[17216]	[17415]	['Discussion\nOur study is the first to evaluate the possible association in general between the effect of maternal infusion treatments during pregnancy and the different variables of fetal development.']	possible	INCOMPLETE_EVIDENCE	[17266]	[17274]	PMC1252725_T35
PMC1252725	PMC1252725_110	[17216]	[17415]	['Discussion\nOur study is the first to evaluate the possible association in general between the effect of maternal infusion treatments during pregnancy and the different variables of fetal development.']	association	SUPERFICIAL_RELATIONSHIP	[17275]	[17286]	PMC1252725_T92
PMC1252725	PMC1252725_110	[17216]	[17415]	['Discussion\nOur study is the first to evaluate the possible association in general between the effect of maternal infusion treatments during pregnancy and the different variables of fetal development.']	effect	SUPERFICIAL_RELATIONSHIP	[17310]	[17316]	PMC1252725_T93
PMC1252725	PMC1252725_112	[17560]	[17658]	['Thus, we were not able to detect any teratogenic potential of infusion treatment during pregnancy.']	Thus	PROBABLE_UNDERSTANDING	[17560]	[17564]	PMC1252725_T71
PMC1252725	PMC1252725_112	[17560]	[17658]	['Thus, we were not able to detect any teratogenic potential of infusion treatment during pregnancy.']	potential	INCOMPLETE_EVIDENCE	[17609]	[17618]	PMC1252725_T36
PMC1252725	PMC1252725_113	[17659]	[17907]	['On the other hand, mean gestational age was shorter and mean birth weight was smaller in control newborn infants without CA born to mothers with infusion treatment during the study pregnancy than in the babies of mothers without infusion treatment.']	On the other hand	ANOMALY_CURIOUS_FINDING	[17659]	[17676]	PMC1252725_T123
PMC1252725	PMC1252725_113	[17659]	[17907]	['On the other hand, mean gestational age was shorter and mean birth weight was smaller in control newborn infants without CA born to mothers with infusion treatment during the study pregnancy than in the babies of mothers without infusion treatment.']	On the other hand	ALTERNATIVE_OPTIONS_CONTROVERSY	[17659]	[17676]	PMC1252725_T142
PMC1252725	PMC1252725_114	[17908]	[18020]	['Thus, infusion of drugs used for the prevention of threatened preterm delivery seems to have a limited efficacy.']	Thus	PROBABLE_UNDERSTANDING	[17908]	[17912]	PMC1252725_T72
PMC1252725	PMC1252725_114	[17908]	[18020]	['Thus, infusion of drugs used for the prevention of threatened preterm delivery seems to have a limited efficacy.']	prevention	SUPERFICIAL_RELATIONSHIP	[17945]	[17955]	PMC1252725_T94
PMC1252725	PMC1252725_114	[17908]	[18020]	['Thus, infusion of drugs used for the prevention of threatened preterm delivery seems to have a limited efficacy.']	seems	ANOMALY_CURIOUS_FINDING	[17987]	[17992]	PMC1252725_T124
PMC1252725	PMC1252725_114	[17908]	[18020]	['Thus, infusion of drugs used for the prevention of threatened preterm delivery seems to have a limited efficacy.']	efficacy	SUPERFICIAL_RELATIONSHIP	[18011]	[18019]	PMC1252725_T95
PMC1252725	PMC1252725_115	[18021]	[18276]	['However, the ratio of threatened preterm delivery was 1 in 3.6 among pregnancy complications instead of the ratio of preterm birth: 1 in 1.8, therefore nearly half of threatened preterm deliveries was effectively treated, therefore it was not inefficient.']	However	ALTERNATIVE_OPTIONS_CONTROVERSY	[18021]	[18028]	PMC1252725_T143
PMC1252725	PMC1252725_115	[18021]	[18276]	['However, the ratio of threatened preterm delivery was 1 in 3.6 among pregnancy complications instead of the ratio of preterm birth: 1 in 1.8, therefore nearly half of threatened preterm deliveries was effectively treated, therefore it was not inefficient.']	instead	ALTERNATIVE_OPTIONS_CONTROVERSY	[18114]	[18121]	PMC1252725_T144
PMC1252725	PMC1252725_115	[18021]	[18276]	['However, the ratio of threatened preterm delivery was 1 in 3.6 among pregnancy complications instead of the ratio of preterm birth: 1 in 1.8, therefore nearly half of threatened preterm deliveries was effectively treated, therefore it was not inefficient.']	therefore	PROBABLE_UNDERSTANDING	[18163]	[18172]	PMC1252725_T73
PMC1252725	PMC1252725_115	[18021]	[18276]	['However, the ratio of threatened preterm delivery was 1 in 3.6 among pregnancy complications instead of the ratio of preterm birth: 1 in 1.8, therefore nearly half of threatened preterm deliveries was effectively treated, therefore it was not inefficient.']	therefore	PROBABLE_UNDERSTANDING	[18243]	[18252]	PMC1252725_T74
PMC1252725	PMC1252725_116	[18277]	[18434]	['In addition, intrauterine growth retardation was found in newborn infants born to mothers with hyperemesis gravidarum on the contrary of infusion treatments.']	found	INCOMPLETE_EVIDENCE	[18326]	[18331]	PMC1252725_T37
PMC1252725	PMC1252725_116	[18277]	[18434]	['In addition, intrauterine growth retardation was found in newborn infants born to mothers with hyperemesis gravidarum on the contrary of infusion treatments.']	contrary	ANOMALY_CURIOUS_FINDING	[18402]	[18410]	PMC1252725_T125
PMC1252725	PMC1252725_117	[18435]	[18645]	["The strengths of the HCCSCA's data set are (i) the large and (ii) population-based cohort including 374 pregnant women with infusion treatment (iii) in an ethnically homogeneous European (Caucasian) population."]	strengths	IMPORTANT_CONSIDERATION	[18439]	[18448]	PMC1252725_T114
PMC1252725	PMC1252725_118	[18646]	[18758]	['(iv) The data of infusion were prospectively collected and medically recorded, thus recall bias can be excluded.']	thus	PROBABLE_UNDERSTANDING	[18725]	[18729]	PMC1252725_T75
PMC1252725	PMC1252725_118	[18646]	[18758]	['(iv) The data of infusion were prospectively collected and medically recorded, thus recall bias can be excluded.']	bias	PROBLEM_COMPLICATION	[18737]	[18741]	PMC1252725_T156
PMC1252725	PMC1252725_119	[18759]	[19025]	['(v) Cases with CA and their controls without CAs were matched, (vi) main confounders were known, (vii) birth weight and gestational age were medically recorded, and (viii) there was a good validity of CA-diagnoses due to the results of recent medical examinations14.']	to	PROBLEM_COMPLICATION	[18977]	[18979]	PMC1252725_T157
PMC1252725	PMC1252725_120	[19026]	[19070]	['However, this data set has also limitations.']	However	ALTERNATIVE_OPTIONS_CONTROVERSY	[19026]	[19033]	PMC1252725_T145
PMC1252725	PMC1252725_120	[19026]	[19070]	['However, this data set has also limitations.']	limitations	INCOMPLETE_EVIDENCE	[19058]	[19069]	PMC1252725_T38
PMC1252725	PMC1252725_121	[19071]	[19178]	['Though the response rate was similar in controls (83%) and cases (84%), there was an active follow-up, i.e.']	Though	ANOMALY_CURIOUS_FINDING	[19071]	[19077]	PMC1252725_T126
PMC1252725	PMC1252725_121	[19071]	[19178]	['Though the response rate was similar in controls (83%) and cases (84%), there was an active follow-up, i.e.']	similar	SUPERFICIAL_RELATIONSHIP	[19100]	[19107]	PMC1252725_T96
PMC1252725	PMC1252725_122	[19179]	[19272]	['a home visit in all no respondent case mothers but only in 200 no respondent control mothers.']	but only	ANOMALY_CURIOUS_FINDING	[19226]	[19234]	PMC1252725_T127
PMC1252725	PMC1252725_123	[19273]	[19420]	['However, the use of drugs in control mothers with no response did not differ significantly from the rate of control pregnant women who responded16.']	However	ANOMALY_CURIOUS_FINDING	[19273]	[19280]	PMC1252725_T128
PMC1252725	PMC1252725_123	[19273]	[19420]	['However, the use of drugs in control mothers with no response did not differ significantly from the rate of control pregnant women who responded16.']	not	ANOMALY_CURIOUS_FINDING	[19339]	[19342]	PMC1252725_T129
PMC1252725	PMC1252725_124	[19421]	[19702]	['Multiple comparison may produce a statistically significant association (p<0.05) in every 20thestimation because of chance and we explain the higher occurrence of renal a/dysgenesis after infusion treatment at the comparison of this CA group with the total control group by chance.']	may	INCOMPLETE_EVIDENCE	[19441]	[19444]	PMC1252725_T39
PMC1252725	PMC1252725_124	[19421]	[19702]	['Multiple comparison may produce a statistically significant association (p<0.05) in every 20thestimation because of chance and we explain the higher occurrence of renal a/dysgenesis after infusion treatment at the comparison of this CA group with the total control group by chance.']	association	SUPERFICIAL_RELATIONSHIP	[19481]	[19492]	PMC1252725_T97
PMC1252725	PMC1252725_124	[19421]	[19702]	['Multiple comparison may produce a statistically significant association (p<0.05) in every 20thestimation because of chance and we explain the higher occurrence of renal a/dysgenesis after infusion treatment at the comparison of this CA group with the total control group by chance.']	explain	PROBABLE_UNDERSTANDING	[19551]	[19558]	PMC1252725_T76
PMC1252725	PMC1252725_125	[19703]	[19857]	['In addition this possible association was based on 3 cases because only one was born to the mother who had infusion in the second month of gestation, i.e.']	possible	INCOMPLETE_EVIDENCE	[19720]	[19728]	PMC1252725_T40
PMC1252725	PMC1252725_125	[19703]	[19857]	['In addition this possible association was based on 3 cases because only one was born to the mother who had infusion in the second month of gestation, i.e.']	association	SUPERFICIAL_RELATIONSHIP	[19729]	[19740]	PMC1252725_T98
PMC1252725	PMC1252725_125	[19703]	[19857]	['In addition this possible association was based on 3 cases because only one was born to the mother who had infusion in the second month of gestation, i.e.']	on	INCOMPLETE_EVIDENCE	[19751]	[19753]	PMC1252725_T41
PMC1252725	PMC1252725_125	[19703]	[19857]	['In addition this possible association was based on 3 cases because only one was born to the mother who had infusion in the second month of gestation, i.e.']	only	INCOMPLETE_EVIDENCE	[19770]	[19774]	PMC1252725_T42
PMC1252725	PMC1252725_127	[19908]	[20004]	['The type of drugs obviously has a greater impact for fetuses than the route of administration17.']	impact	SUPERFICIAL_RELATIONSHIP	[19950]	[19956]	PMC1252725_T99
PMC1252725	PMC1252725_128	[20005]	[20159]	['Thus it is not possible to evaluate the impact of an administration route (namely infusion in this study) without taking into account the different drugs.']	Thus	PROBABLE_UNDERSTANDING	[20005]	[20009]	PMC1252725_T77
PMC1252725	PMC1252725_128	[20005]	[20159]	['Thus it is not possible to evaluate the impact of an administration route (namely infusion in this study) without taking into account the different drugs.']	not possible	DIFFICULT_TASK	[20016]	[20028]	PMC1252725_T3
PMC1252725	PMC1252725_128	[20005]	[20159]	['Thus it is not possible to evaluate the impact of an administration route (namely infusion in this study) without taking into account the different drugs.']	impact	SUPERFICIAL_RELATIONSHIP	[20045]	[20051]	PMC1252725_T100
PMC1252725	PMC1252725_129	[20160]	[20269]	['However, the major reason of infusion in pregnant women with hyperemesis gravidarum is the fluid replacement.']	However	ALTERNATIVE_OPTIONS_CONTROVERSY	[20160]	[20167]	PMC1252725_T146
PMC1252725	PMC1252725_129	[20160]	[20269]	['However, the major reason of infusion in pregnant women with hyperemesis gravidarum is the fluid replacement.']	major	IMPORTANT_CONSIDERATION	[20173]	[20178]	PMC1252725_T115
PMC1252725	PMC1252725_129	[20160]	[20269]	['However, the major reason of infusion in pregnant women with hyperemesis gravidarum is the fluid replacement.']	reason	PROBABLE_UNDERSTANDING	[20179]	[20185]	PMC1252725_T78
PMC1252725	PMC1252725_130	[20270]	[20380]	['The teratogenic potential of antiemetic drugs used in Hungary parallel with infusion was evaluated previously.']	potential	INCOMPLETE_EVIDENCE	[20286]	[20295]	PMC1252725_T43
PMC1252725	PMC1252725_130	[20270]	[20380]	['The teratogenic potential of antiemetic drugs used in Hungary parallel with infusion was evaluated previously.']	previously	INCOMPLETE_EVIDENCE	[20369]	[20379]	PMC1252725_T44
PMC1252725	PMC1252725_131	[20381]	[20586]	['A weak association was found between thiethylperazine and cleft lip ± palate18, there was no teratogenic potential of dimenhydrinate19, while vitamin B6 showed a protective effect for cardiovascular CAs20.']	association	SUPERFICIAL_RELATIONSHIP	[20388]	[20399]	PMC1252725_T101
PMC1252725	PMC1252725_131	[20381]	[20586]	['A weak association was found between thiethylperazine and cleft lip ± palate18, there was no teratogenic potential of dimenhydrinate19, while vitamin B6 showed a protective effect for cardiovascular CAs20.']	found	INCOMPLETE_EVIDENCE	[20404]	[20409]	PMC1252725_T45
PMC1252725	PMC1252725_131	[20381]	[20586]	['A weak association was found between thiethylperazine and cleft lip ± palate18, there was no teratogenic potential of dimenhydrinate19, while vitamin B6 showed a protective effect for cardiovascular CAs20.']	potential	INCOMPLETE_EVIDENCE	[20486]	[20495]	PMC1252725_T46
PMC1252725	PMC1252725_131	[20381]	[20586]	['A weak association was found between thiethylperazine and cleft lip ± palate18, there was no teratogenic potential of dimenhydrinate19, while vitamin B6 showed a protective effect for cardiovascular CAs20.']	while	ALTERNATIVE_OPTIONS_CONTROVERSY	[20517]	[20522]	PMC1252725_T147
PMC1252725	PMC1252725_131	[20381]	[20586]	['A weak association was found between thiethylperazine and cleft lip ± palate18, there was no teratogenic potential of dimenhydrinate19, while vitamin B6 showed a protective effect for cardiovascular CAs20.']	showed	INCOMPLETE_EVIDENCE	[20534]	[20540]	PMC1252725_T47
PMC1252725	PMC1252725_131	[20381]	[20586]	['A weak association was found between thiethylperazine and cleft lip ± palate18, there was no teratogenic potential of dimenhydrinate19, while vitamin B6 showed a protective effect for cardiovascular CAs20.']	protective	SUPERFICIAL_RELATIONSHIP	[20543]	[20553]	PMC1252725_T102
PMC1252725	PMC1252725_131	[20381]	[20586]	['A weak association was found between thiethylperazine and cleft lip ± palate18, there was no teratogenic potential of dimenhydrinate19, while vitamin B6 showed a protective effect for cardiovascular CAs20.']	effect	SUPERFICIAL_RELATIONSHIP	[20554]	[20560]	PMC1252725_T103
PMC1252725	PMC1252725_132	[20587]	[20727]	['The other main indication of infusion therapy was threatened preterm delivery and it was combined with terbutaline, fenoterol and verapamil.']	other	ALTERNATIVE_OPTIONS_CONTROVERSY	[20591]	[20596]	PMC1252725_T148
PMC1252725	PMC1252725_135	[20834]	[20965]	['We need further studies to evaluate in general the efficacy of different drugs according to administration route in pregnant women.']	need	FUTURE_WORK	[20837]	[20841]	PMC1252725_T105
PMC1252725	PMC1252725_135	[20834]	[20965]	['We need further studies to evaluate in general the efficacy of different drugs according to administration route in pregnant women.']	further studies	FUTURE_WORK	[20842]	[20857]	PMC1252725_T106
PMC1252725	PMC1252725_135	[20834]	[20965]	['We need further studies to evaluate in general the efficacy of different drugs according to administration route in pregnant women.']	different	ALTERNATIVE_OPTIONS_CONTROVERSY	[20897]	[20906]	PMC1252725_T149
PMC1252725	PMC1252725_136	[20966]	[21131]	['The intravenous route is used for the administration of medications when immediate or special drug action is required due to the severity of pathological conditions.']	required	IMPORTANT_CONSIDERATION	[21075]	[21083]	PMC1252725_T116
PMC1252725	PMC1252725_136	[20966]	[21131]	['The intravenous route is used for the administration of medications when immediate or special drug action is required due to the severity of pathological conditions.']	due to	PROBLEM_COMPLICATION	[21084]	[21090]	PMC1252725_T158
PMC1252725	PMC1252725_137	[21132]	[21258]	['Nevertheless, a teratogenic potential of infusion treatment and/or drugs, in addition underlying pregnancy complications (e.g.']	Nevertheless	ALTERNATIVE_OPTIONS_CONTROVERSY	[21132]	[21144]	PMC1252725_T150
PMC1252725	PMC1252725_137	[21132]	[21258]	['Nevertheless, a teratogenic potential of infusion treatment and/or drugs, in addition underlying pregnancy complications (e.g.']	potential	INCOMPLETE_EVIDENCE	[21160]	[21169]	PMC1252725_T48
PMC1252725	PMC1252725_137	[21132]	[21258]	['Nevertheless, a teratogenic potential of infusion treatment and/or drugs, in addition underlying pregnancy complications (e.g.']	complications	PROBLEM_COMPLICATION	[21239]	[21252]	PMC1252725_T159
PMC1252725	PMC1252725_138	[21259]	[21321]	['dehydration) during pregnancy was not detectable in our study.']	our study	QUESTION_ANSWERED_BY_THIS_WORK	[21311]	[21320]	PMC1252725_T165
PMC1252725	PMC1252725_140	[21437]	[21553]	['In fact, mothers who had infusion treatment later delivered boys with a lower risk for hypospadias and multiple CAs.']	In fact	ANOMALY_CURIOUS_FINDING	[21437]	[21444]	PMC1252725_T130
PMC1252725	PMC1252725_140	[21437]	[21553]	['In fact, mothers who had infusion treatment later delivered boys with a lower risk for hypospadias and multiple CAs.']	risk	IMPORTANT_CONSIDERATION	[21515]	[21519]	PMC1252725_T117
PMC1252725	PMC1252725_141	[21554]	[21601]	['These unexpected findings need further studies.']	unexpected	INCOMPLETE_EVIDENCE	[21560]	[21570]	PMC1252725_T49
PMC1252725	PMC1252725_141	[21554]	[21601]	['These unexpected findings need further studies.']	unexpected	ANOMALY_CURIOUS_FINDING	[21560]	[21570]	PMC1252725_T131
PMC1252725	PMC1252725_141	[21554]	[21601]	['These unexpected findings need further studies.']	findings	INCOMPLETE_EVIDENCE	[21571]	[21579]	PMC1252725_T50
PMC1252725	PMC1252725_141	[21554]	[21601]	['These unexpected findings need further studies.']	need	FUTURE_WORK	[21580]	[21584]	PMC1252725_T107
PMC1252725	PMC1252725_141	[21554]	[21601]	['These unexpected findings need further studies.']	further studies	FUTURE_WORK	[21585]	[21600]	PMC1252725_T108
PMC1252725	PMC1252725_143	[21749]	[21902]	['These findings may indicate the limited value of this treatment because these pregnant women had also a significantly higher proportion of preterm birth.']	These findings	INCOMPLETE_EVIDENCE	[21749]	[21763]	PMC1252725_T51
PMC1252725	PMC1252725_143	[21749]	[21902]	['These findings may indicate the limited value of this treatment because these pregnant women had also a significantly higher proportion of preterm birth.']	may	INCOMPLETE_EVIDENCE	[21764]	[21767]	PMC1252725_T52
PMC1252725	PMC1252725_143	[21749]	[21902]	['These findings may indicate the limited value of this treatment because these pregnant women had also a significantly higher proportion of preterm birth.']	indicate	INCOMPLETE_EVIDENCE	[21768]	[21776]	PMC1252725_T53
PMC1252725	PMC1252725_143	[21749]	[21902]	['These findings may indicate the limited value of this treatment because these pregnant women had also a significantly higher proportion of preterm birth.']	limited	INCOMPLETE_EVIDENCE	[21781]	[21788]	PMC1252725_T54
PMC1252725	PMC1252725_144	[21903]	[22044]	['In addition, babies born to mothers with hyperemesis gravidarum showed intrauterine growth retardation on the contrary of infusion treatment.']	showed	INCOMPLETE_EVIDENCE	[21967]	[21973]	PMC1252725_T55
PMC1252725	PMC1252725_144	[21903]	[22044]	['In addition, babies born to mothers with hyperemesis gravidarum showed intrauterine growth retardation on the contrary of infusion treatment.']	contrary	ANOMALY_CURIOUS_FINDING	[22013]	[22021]	PMC1252725_T132
PMC1252725	PMC1252725_145	[22045]	[22137]	['Similar findings were not found in women with severe nausea and vomiting during pregnancy23.']	Similar findings	INCOMPLETE_EVIDENCE	[22045]	[22061]	PMC1252725_T56
PMC1252725	PMC1252725_145	[22045]	[22137]	['Similar findings were not found in women with severe nausea and vomiting during pregnancy23.']	not found	INCOMPLETE_EVIDENCE	[22067]	[22076]	PMC1252725_T57
PMC1252725	PMC1252725_145	[22045]	[22137]	['Similar findings were not found in women with severe nausea and vomiting during pregnancy23.']	severe	IMPORTANT_CONSIDERATION	[22091]	[22097]	PMC1252725_T118
PMC1252725	PMC1252725_146	[22138]	[22273]	['In conclusion, the results of our study suggest that infusion treatment of pregnant women did not associate with a higher risk for CAs.']	our study	QUESTION_ANSWERED_BY_THIS_WORK	[22168]	[22177]	PMC1252725_T166
PMC1252725	PMC1252725_146	[22138]	[22273]	['In conclusion, the results of our study suggest that infusion treatment of pregnant women did not associate with a higher risk for CAs.']	suggest	INCOMPLETE_EVIDENCE	[22178]	[22185]	PMC1252725_T58
PMC1252725	PMC1252725_146	[22138]	[22273]	['In conclusion, the results of our study suggest that infusion treatment of pregnant women did not associate with a higher risk for CAs.']	risk	IMPORTANT_CONSIDERATION	[22260]	[22264]	PMC1252725_T119
PMC1252725	PMC1252725_147	[22274]	[22428]	['The intravenous infusion of drugs have some, but limited efficacy to prevent the adverse effect of hyperemesis gravidarum and threatened preterm delivery.']	some	INCOMPLETE_EVIDENCE	[22313]	[22317]	PMC1252725_T59
PMC1252725	PMC1252725_147	[22274]	[22428]	['The intravenous infusion of drugs have some, but limited efficacy to prevent the adverse effect of hyperemesis gravidarum and threatened preterm delivery.']	but	ALTERNATIVE_OPTIONS_CONTROVERSY	[22319]	[22322]	PMC1252725_T151
PMC1252725	PMC1252725_147	[22274]	[22428]	['The intravenous infusion of drugs have some, but limited efficacy to prevent the adverse effect of hyperemesis gravidarum and threatened preterm delivery.']	limited	INCOMPLETE_EVIDENCE	[22323]	[22330]	PMC1252725_T60
PMC1252725	PMC1252725_147	[22274]	[22428]	['The intravenous infusion of drugs have some, but limited efficacy to prevent the adverse effect of hyperemesis gravidarum and threatened preterm delivery.']	effect	SUPERFICIAL_RELATIONSHIP	[22363]	[22369]	PMC1252725_T104
PMC1252725	PMC1252725_149	[22467]	[22498]	['This is an open access article.']	This	QUESTION_ANSWERED_BY_THIS_WORK	[22467]	[22471]	PMC1252725_T167
